Compare Humana Inc (HUM) vs Annaly Capital Management, Inc. (NLY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Humana Inc vs Annaly Capital Management, Inc. — how do they compare? Humana Inc trades at $437.2 (market cap $47.61B), while Annaly Capital Management, Inc. trades at $18.41 (market cap $13.51B). The key difference: Humana Inc is far larger — about 3.5× Annaly Capital Management, Inc.'s market cap, and Annaly Capital Management, Inc. pays the higher dividend (16.73%). Which is the better fit depends on your goals — on Pluang, investors hold Humana Inc for 53 Days and Annaly Capital Management, Inc. for 92 Days on average.
| HUM | NLY | |
|---|---|---|
Market Cap | $47.61B | $13.51B |
Volume | 1,827,332 | 18,617,936 |
Sector | Health | Real Estate |
52-Week High | $409.85 | $24.40 |
52-Week Low | $163.67 | $17.93 |
Typical Hold Time | 53 Days | 92 Days |
Enterprise Value | $54.97B | $135.54B |
Dividend Yield | 0.89% | 16.73% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Humana (HUM) trades at $387.12, down 4.24% today, but maintains a bullish technical outlook with strong institutional support. The stock shows mixed fundamentals with revenue growth to $129.66B in 2025 but declining profit margins at 0.88%. Recent analyst upgrades, including Barclays' $515 target on September 25, 2026, highlight optimism despite ongoing Medicare Advantage plan adjustments affecting member transitions.
Investment outlook remains cautiously optimistic with a consensus price target of $432.63 offering 12% upside. Risks include margin compression, regulatory scrutiny from Medicare billing practices, and competitive pressures in managed care. The company's strong cash position of $20.44B and consistent dividend payments provide stability amid enrollment volatility.
NLY trades at $18.27, down 0.81% on the day, with a bearish technical signal from moving averages but bullish oscillators. The stock shows strong profitability with a 92.77% net income margin and 20.66% ROE, trading below book value at a P/B of 0.89. Recent earnings beats and a high 14.7% dividend yield attract income investors, though the stock faces pressure from rising mortgage rates and volatile cash flows.
The outlook is mixed: analyst consensus is bullish with a $22 price target, but technical weakness and interest rate sensitivity pose risks. The expanding MBS portfolio supports earnings growth, yet high leverage and macroeconomic headwinds require careful monitoring for dividend sustainability and capital appreciation potential.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
No sentiment data available yet.
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Humana Inc
Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.
Read more on HUM →About Annaly Capital Management, Inc.
Annaly Capital Management Inc is an American mortgage real estate investment trust. The company segments its operations into Residential and Commercial real estate investments. While Annaly's Residential assets are primarily comprised of agency mortgage-backed securities and debentures, it is primarily invested in commercial mortgage loans and mortgage-backed securities in its Commercial unit through its subsidiary, Annaly Commercial Real Estate Group. Agency mortgage-backed securities and debentures make up the majority of the company's overall portfolio. Most of the company's counterparties are located in the U.S. Annaly generates nearly all of its revenue from the spread between interest earned on its assets and interest payments made on its borrowings.
Read more on NLY →
